400-8-075
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 0mg | ￥ ƐƚǺƅǺǺ | -- | -- | -- | -- | -- | -- | ￥ ƐƚǺƅǺǺ | - + |
| 50mg | ￥ œȋǺǺƅǺǺ | -- | -- | -- | -- | -- | -- | ￥ œȋǺǺƅǺǺ | - + |
57.53
[]. Ainslie GR, et al. A pharmacokinetic evaluation and metabolite identification of the GHB receptor antagonist NCS-38 in mouse informs novel therapeutic strategies for the treatment of GHB intoxication. Pharmacol Res Perspect. 06 Oct 8;4(6):e0065.
[]. Maitre M, Hechler V, Vayer P, Gobaille S, Cash CD, Schmitt M, Bourguignon JJ. A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J Pharmacol Exp Ther. 990 Nov;55():657-63.
[3]. Schmidt C, et al. Anti-sedative and anti-cataleptic properties of NCS-38, a gamma-hydroxybutyrate receptor antagonist. Eur J Pharmacol. 99 Oct ;03(3):393-7.
[4]. Vogel KR, et al. In vitro toxicological evaluation of NCS-38, a high-affinity antagonist of γ-hydroxybutyrate (GHB) binding. Toxicol In Vitro. 07 Apr;40:96-0
H30-H35-H39-H335
P6-P64-P70-P7-P80-P30+P35-P304+P340-P330-P36+P364-P405-P50
064 货期咨询
7640 货期咨询
￥ şƚşƚƅǺǺ -g
07467 货期咨询
75 货期咨询
￥ džŸȤȤƅǺǺ -g
39809 货期咨询
￥ ȋƚǠȤƅǺǺ -g
3008 货期咨询
6840 货期咨询
03596 货期咨询
￥ ȋƚȋȋƅǺǺ -g
68406 货期咨询
7568 货期咨询
沪ICP备709645号
